Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Canada
Deutschland
España
France
Italia
Schweiz (DE)
Suisse (FR)
United Kingdom
United States
Settings
Dynamic quotes
OFF
ON
Markets
Equities
North America
Europe
Asia
Oceania
Middle East
»
More Equities
Indexes
DOW JONES
S&P 500
NASDAQ 100
TSX COMP
NIKKEI 225
»
More Indexes
Currency / Forex
EUR / USD
GBP / USD
USD / JPY
USD / CAD
AUD / USD
»
More Currencies
Commodities
GOLD
Crude Oil (WTI)
Crude Oil (BRENT)
SILVER
PLATINUM
»
More Commodities
Trackers & ETF
Rankings and News
Advanced Search
Cryptocurrencies
BITCOIN
ETHEREUM
News
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Business Leaders
Cryptocurrencies
Cybersecurity
Economic calendar
Listed companies
Analyst reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit warnings
Appointments
Press Releases
Events
Corporate actions
Financial calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Telecommunications Services
Utilities
Analysis
All Analysis
Must Read
Daily briefing
Weekly market update
Stock Trading Strategies
Stock Picks
All stock picks
Subscribe
Portfolios
My Portfolio
Virtual portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment style
Yield stocks
Growth stocks
Undervalued Stocks
Investment themes
Strategic Metals
The Cannabis Industry
The Golden Age of Video Games
US Basketball
Green Energie
In Vino Veritas
The Vegan Market
French state ownership
Education
Top / Flop
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
Screeners
Investment selections
Strategic Metals
The Cannabis Industry
The Golden Age of Video Games
US Basketball
Green Energie
In Vino Veritas
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic chart
Financial calendar
Economic calendar
Sector research
Currency converter
ProRealTime Trading
Our Services
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
MarketScreener Homepage
>
Equities
>
Swiss Exchange
>
Roche Holding AG
ROG
CH0012032048
ROCHE HOLDING AG
(ROG)
Add to my list
Report
Delayed Swiss Exchange -
01/22 11:30:30 am
318.45
CHF
+0.54%
01/22
ROCHE HOLDINGS AG
: Barclays reiterates its Buy rating
MD
01/21
ROCHE
: Genentech's Esbriet Gets FDA Priority Review in Unclassifiable Interstitial Lung Disease
DJ
01/21
ROCHE
: US FDA Accepts Roche's Lung Disease Therapy Esbriet For New Drug Review
MT
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
MarketScreener Strategies
Communiqués de presse de la société ROCHE HOLDING AG
01/21
ROCHE
: FDA grants priority review to Roche's Esbriet (pirfenidone) for unclassi..
PU
01/21
ROCHE
: FDA Grants Priority Review to Genentech's Esbriet (pirfenidone) for Uncl..
BU
01/19
CHUGAI PHARMACEUTICAL
: Supports the Japan Climate Initiative's Calling to Raise..
AQ
01/18
ROCHE ANNUAL GENERAL MEETING 2021
: Exercising of shareholder rights via the ind..
AQ
01/13
CHUGAI PHARMACEUTICAL
: Conducts Digital Transformation in Manufacturing with IB..
AQ
01/12
ROCHE
: confirms US government agreement to purchase additional doses of Regener..
AQ
01/12
ROCHE
: CHEPLAPHARM acquires the rights to Rivotril
AQ
01/12
ROCHE
: to present updated data confirming Tecentriq in combination with Avastin..
AQ
01/11
ROCHE
: Xofluza approved by the European Commission for the treatment of influen..
AQ
01/11
ROCHE
: launches two digital pathology image analysis algorithms for precision p..
AQ
01/11
ROCHE
: Xofluza approved by the European Commission for the treatment of influen..
AQ
01/05
ROCHE
: Invitation to Roche's Full Year Results 2020 Presentation
PU
01/05
GENENTECH
: 's Novel Anti-TIGIT Tiragolumab Granted FDA Breakthrough Therapy Des..
BU
01/05
ROCHE
: novel anti-TIGIT tiragolumab granted FDA Breakthrough Therapy Designatio..
AQ
2020
Chugai Obtains Approval for Expanded Use of FoundationOne CDx Cancer Genomic ..
AQ
2020
HALOZYME THERAPEUTICS
: Announces Roche Receives European Commission Approval fo..
AQ
2020
CHUGAI PHARMACEUTICAL THE
: Launch of Chugai's New TV Commercial Featuring Erika..
AQ
2020
ROCHE
: European Commission approves Roche's Phesgo (fixed-dose combination of P..
AQ
2020
CHUGAI PHARMACEUTICAL
: Osteoporosis Agent Edirol Obtains Regulatory Approval in..
AQ
2020
ROCHE
: faricimab meets primary endpoint and shows strong durability across two ..
AQ
2020
GENENTECH
: 's Faricimab Meets Primary Endpoint and Shows Strong Durability Acro..
BU
2020
REGENERON PHARMACEUTICALS
: New England Journal of Medicine Publishes Positive I..
AQ
2020
ROCHE
: Diagnostics to create Software Development Hub in Laval, Quebec
AQ
2020
ROCHE
: FDA Approves Genentech's Ocrevus Shorter 2-Hour Infusion for Relapsing a..
AQ
2020
ROCHE
: launches cobas PIK3CA Mutation Test for patients with advanced or metast..
AQ
2020
ROCHE
: FDA approves Roche's OCREVUS® (ocrelizumab) shorter 2-hour infusion for ..
AQ
2020
ROCHE
: FDA Approves Genentech's Ocrevus (ocrelizumab) Shorter 2-Hour Infusion f..
BU
2020
CHUGAI PHARMACEUTICAL
: in-licenses Antibody Cocktail for COVID-19 from Roche
AQ
2020
ROCHE
: launches laboratory SARS-CoV-2 antigen test to support high-volume testi..
AQ
2020
ROCHE
: presents exploratory data from the Phase III IMvigor010 study in early b..
AQ
2020
ROCHE
: UC Davis - The next generation of combined COVID-19 and flu test rolls o..
AQ
2020
CURIS
: Announces Positive Preliminary Data from Ongoing Phase 1 Study of CA-494..
AQ
2020
ROCHE
: New Roche antibody test to be used in Moderna COVID-19 vaccine trial
AQ
2020
ROCHE
: partners with Moderna to include SARS-CoV-2 antibody test in ongoing COV..
AQ
2020
ROCHE
: New follow-up phase III data reinforce the long-term benefit of Roche's ..
AQ
2020
CURIS
: Announces Updated Preliminary Data from Ongoing Phase 1 Study of CA-4948..
AQ
2020
ROCHE
: presents new data from its bispecific antibody portfolio across a range ..
AQ
2020
ROCHE
: announces new data reinforcing the long-term benefit of Venclexta/Vencly..
AQ
2020
ROCHE
: New data presented at ASH 2020 reinforces the benefit/risk profile of fi..
AQ
2020
ROCHE
: New follow-up phase III data reinforce the long-term benefit of Roche's ..
AQ
2020
ROCHE
: announces new data reinforcing the long-term benefit of Venclexta/Vencly..
AQ
2020
GENENTECH
: Announces New Data Reinforcing the Long-Term Benefit of Venclexta-Ba..
BU
2020
ROCHE
: Genentech Announces FDA Approval of Gavreto for People With Advanced or ..
AQ
2020
ROCHE
: announces FDA approval of Gavreto (pralsetinib) for people with advanced..
AQ
2020
ROCHE
: receives FDA Emergency Use Authorization for new test to measure the lev..
AQ
2020
GENENTECH
: Announces FDA Approval of Gavreto (pralsetinib) for People With Adva..
BU
2020
ROCHE
: FDA approves Xolair® (omalizumab) for adults with nasal polyps
AQ
2020
GENENTECH
: Announces FDA Approval of Xolair (omalizumab) for Adults with Nasal ..
BU
2020
REMINDER
: Invitation to Roche's virtual event on key hematology data presented ..
PU
2020
Chugai Files Patent Infringement Lawsuit concerning Edirol Capsules
AQ
2020
Chugai and DeNA Jointly Launch 'Ring Again,' a Rheumatoid Arthritis Disease A..
AQ
2020
SHIONOGI
: Announces FDA Approval of XOFLUZA for the prevention of Influenza fol..
AQ
2020
ROCHE
: Genentech Announces FDA Approval of Xofluza for the Prevention of Influe..
AQ
2020
ROCHE
: announces FDA approval of Xofluza for the prevention of influenza follow..
PU
2020
ROCHE
: announces FDA approval of Xofluza for the prevention of influenza follow..
PU
2020
ROCHE
: announces FDA approval of Xofluza for the prevention of influenza follow..
AQ
2020
GENENTECH
: Announces FDA Approval of Xofluza for the Prevention of Influenza Fo..
BU
2020
ROCHE
: Regeneron's REGN-COV2 is first antibody cocktail for COVID-19 to receive..
PU
2020
CHUGAI PHARMACEUTICAL
: Receives the Best IR Award
AQ
2020
CHUGAI PHARMACEUTICAL
: Selected for the First Time in the 'DJSI World,' a Globa..
AQ
2020
DICERNA PHARMACEUTICALS
: Announces Positive Updated Data from Phase 1 Trial of ..
AQ
2020
SPARK THERAPEUTICS
: Expands Visionary Leadership with Appointment of Michael Re..
AQ
2020
ROCHE
: Leading Diagnostics Companies Join Forces to Establish the Access to Com..
PR
2020
ROCHE
: CHMP recommends EU approval of Roche's Xofluza for the treatment of infl..
AQ
2020
HALOZYME THERAPEUTICS
: Announces CHMP Recommends EU Approval of Roche's Phesgo ..
AQ
2020
ROCHE
: Spark Therapeutics Expands Visionary Leadership with Appointment of Mich..
AQ
2020
ROCHE
: CHMP recommends EU approval of Roche's Xofluza® (baloxavir marboxil) for..
AQ
2020
ROCHE
: ranked the most sustainable healthcare company in the Dow Jones Sustaina..
AQ
2020
ROCHE
: CHMP recommends EU approval of Roche's Xofluza® (baloxavir marboxil) for..
PU
2020
ROCHE
: CHMP recommends EU approval of Roche's Xofluza® (baloxavir marboxil) for..
AQ
2020
ROCHE
: UC Davis - New cutting-edge rapid test detects both COVID-19 and flu
AQ
2020
ROCHE
: CHMP recommends EU approval of Roche's Phesgo (fixed-dose combination of..
PU
2020
ROCHE
: CHMP recommends EU approval of Roche's Phesgo (fixed-dose combination of..
AQ
2020
CURIS
: Reports Third Quarter 2020 Financial Results
AQ
2020
CURIS
: Announces Collaboration with the National Cancer Institute for the Devel..
AQ
1
2
3
4
5
6
7
8
9
10
Next
Analysis
AstraZeneca shares fall on 'hefty' $39-billion Alexion deal
More Must read
Stock Trading Strategies
TRADING
Close to an important medium term support level
More Stock Trading Analysis
Upcoming event on ROCHE HOLDING AG
01/28/21
International Association for the Study of Lung Cancer World Conference
Company calendar
Upcoming sector events
01/26/21
JOHNSON & JOHNSON
: FY 2020 Earnings Release
01/26/21
NOVARTIS AG
: FY 2020 Earnings Release
01/28/21
LUPIN LIMITED
: Q3 2021 Earnings Release
01/28/21
SUMITOMO DAINIPPON PHARMA CO., LTD.
: Q3 2020 Earnings Release
More events
Sector
Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Pharmaceuticals - NEC
Master